User profiles for Thomas Witzig
Thomas Witzig, MDProfessor of Medicine, Mayo Clinic Verified email at mayo.edu Cited by 80427 |
Targeting apoptosis pathways in cancer therapy
IM Ghobrial, TE Witzig, AA Adjei - CA: a cancer journal for …, 2005 - Wiley Online Library
Apoptosis, or programmed cell death, is a mechanism by which cells undergo death to
control cell proliferation or in response to DNA damage. The understanding of apoptosis has …
control cell proliferation or in response to DNA damage. The understanding of apoptosis has …
Rituximab for IgG4-related disease: a prospective, open-label trial
…, MD Topazian, A Khosroshahi, TE Witzig… - Annals of the …, 2015 - ard.bmj.com
Objectives To evaluate the efficacy of rituximab (RTX) in IgG4-related disease (IgG4-RD) in
an open-label pilot trial. Methods We treated 30 IgG4-RD patients with two doses of RTX (…
an open-label pilot trial. Methods We treated 30 IgG4-RD patients with two doses of RTX (…
POEMS syndrome: definitions and long-term outcome: Presented in abstract form at the 41st annual meeting of the American Society of Hematology, New Orleans, LA …
…, DR Larson, PR Greipp, TE Witzig… - Blood, The Journal …, 2003 - ashpublications.org
The POEMS syndrome (coined to refer to polyneuropathy, organomegaly, endocrinopathy,
M protein, and skin changes) remains poorly understood. Ambiguity exists over the features …
M protein, and skin changes) remains poorly understood. Ambiguity exists over the features …
Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience
Background There is a paucity of data on long-term management of type 1 autoimmune
pancreatitis (AIP), a relapsing steroid-responsive disorder. Objective We describe our …
pancreatitis (AIP), a relapsing steroid-responsive disorder. Objective We describe our …
Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma
…, TM Habermann, JP Colgan, TE Witzig… - Journal of Clinical …, 2005 - ascopubs.org
Purpose Bleomycin pulmonary toxicity (BPT) has been well described in Hodgkin's lymphoma
(HL) patients treated with bleomycin-containing chemotherapy regimens. The influence of …
(HL) patients treated with bleomycin-containing chemotherapy regimens. The influence of …
Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy
Purpose Studies of diffuse large B-cell lymphoma (DLBCL) are typically evaluated by using
a time-to-event approach with relapse, re-treatment, and death commonly used as the events…
a time-to-event approach with relapse, re-treatment, and death commonly used as the events…
Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma
We report the results of a phase 2 trial using lenalidomide plus dexamethasone (Rev/Dex)
as initial therapy for myeloma. Thirtyfour patients were enrolled. Lenalidomide was given …
as initial therapy for myeloma. Thirtyfour patients were enrolled. Lenalidomide was given …
[HTML][HTML] Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma
Background In a phase 1 trial, axicabtagene ciloleucel (axi-cel), an autologous anti-CD19
chimeric antigen receptor (CAR) T-cell therapy, showed efficacy in patients with refractory …
chimeric antigen receptor (CAR) T-cell therapy, showed efficacy in patients with refractory …
Review of 1027 patients with newly diagnosed multiple myeloma
… Six years later, William Macintyre described the illness of Thomas Alexander McBean, who
had severe bone pain and at autopsy was found to have cells in the bone marrow consistent …
had severe bone pain and at autopsy was found to have cells in the bone marrow consistent …
[HTML][HTML] Effective surgical adjuvant therapy for high-risk rectal carcinoma
…, RF Morton, MH Veeder, TE Witzig… - … England Journal of …, 1991 - Mass Medical Soc
Background Radiation therapy as an adjunct to surgery for rectal cancer has been shown to
reduce local recurrence but has not improved survival. In a previous study, combined …
reduce local recurrence but has not improved survival. In a previous study, combined …